Construction and characterization of efficient, stable and safe replication-deficient foamy virus vectors
- 4 January 2007
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 14 (7) , 613-620
- https://doi.org/10.1038/sj.gt.3302890
Abstract
As serious side effects affected recent virus-mediated gene transfer studies, novel vectors with improved safety profiles are urgently needed. In the present study, replication-deficient retroviral vectors based on feline foamy virus (FFV) were constructed and analyzed. The novel FFV vectors are devoid of almost the complete env gene plus the internal promoter – accessory bel gene cassette including the gene for the viral transcriptional transactivator Bel1/Tas. In these Bel1/Tas-independent vectors, expression of the lacZ (-galactosidase) marker gene is directed by the heterologous, constitutively active human ubiquitin C promoter (ubi). Env-transcomplemented vectors have un-concentrated titers of more than 105 transducing units/ml. The vectors allow efficient transduction of a broad array of diverse target cells, which can be increased by repeated vector exposure. However, the number of lacZ marker gene expressing cells decreased slightly upon serial passages of the transduced cells. Vectors carrying a self-inactivating (SIN) deletion of the TATA box and most parts of the viral promoter were not rescued by wt FFV whereas those with the intact or a partially deleted promoter were readily reactivated. This finding indicates that the viral promoters are in fact non-functional, pointing to a highly advantageous safety profile of these new FFV-ubi-lacZ-SIN vectors.Keywords
This publication has 49 references indexed in Scilit:
- GENE THERAPY: Twenty-First Century MedicineAnnual Review of Biochemistry, 2005
- Experimental therapy of allogeneic solid tumors induced in athymic mice with suicide gene-transducing replication-competent foamy virus vectorsCancer Gene Therapy, 2005
- Stable inhibition of hepatitis B virus proteins by small interfering RNA expressed from viral vectorsThe Journal of Gene Medicine, 2005
- Kinetics and characteristics of replication-competent revertants derived from self-inactivating foamy virus vectorsGene Therapy, 2004
- Chance or necessity? Insertional Mutagenesis in Gene Therapy and Its ConsequencesMolecular Therapy, 2004
- Application of Chimeric Feline Foamy Virus-Based Retroviral Vectors for the Induction of Antiviral Immunity in CatsJournal of Virology, 2003
- Comparison of Three Retroviral Vector Systems for Transduction of Nonobese Diabetic/Severe Combined Immunodeficiency Mice Repopulating Human CD34+Cord Blood CellsHuman Gene Therapy, 2003
- Foamy Virus VectorsPublished by Springer Nature ,2003
- Construction and Functional Characterization of Feline Foamy Virus-Based Retroviral VectorsVirology, 2002
- Lentivirus and foamy virus vectors: novel gene therapy toolsExpert Opinion on Biological Therapy, 2001